Skip to main content
Clinical Trials/CTRI/2016/12/007596
CTRI/2016/12/007596
Active, not recruiting
Phase 3

To identify and quantify extravascular lung water volume by lung ultrasound in oncosurgical patients undergoing CRS and HIPEC under anaesthesia.

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- ASA i-III patients undergoing cytoreductive surgery and peritonectomy.
Sponsor
Rajiv Gandhi Cancer Institute and Research centre
Enrollment
30
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients scheduled for cytoreductive surgery and HIPEC(hyperthermic intraperitoneal chemotherpy) for major abdominal surgery.

Exclusion Criteria

  • Contraindication to femoral artery cathertization (infection at site of procedure, significant valvular heart disease, severe peripheral vascular disease, aortic aneurysm).
  • Cardiac arrhythmias.

Outcomes

Primary Outcomes

Not specified

Similar Trials